12-Month Air Pollution Exposure and the Risk of CRS by Nasal Polyp Status in ADSMs
Pollutants . | Model . | CRS without nasal-polyps . | CRS with nasal polyps . | ||
---|---|---|---|---|---|
n (case/control) . | ORs (95% CI) . | n (case/control) . | ORs (95% CI) . | ||
PM2.5 | Model 1 | 308/308 | 7.19 (2.54, 20.36) | 91/91 | 3.98 (0.88, 18.01) |
Model 2 | 308/308 | 3.32 (0.63, 17.40) | 91/91 | 3.76 (0.35, 39.85) | |
PM10 | Model 1 | 213/213 | 0.97 (0.67, 1.40) | 66/66 | 1.10 (0.75, 1.62) |
Model 2 | 213/213 | 0.97 (0.49, 1.91) | 66/66 | 7.34 (0.83, 65.00) | |
NO2 | Model 1 | 132/132 | 0.65 (0.36, 1.18) | 35/35 | 0.89 (0.37, 2.15) |
Model 2 | 132/132 | 0.85 (0.27, 2.69) | 35/35 | 2.37 (0.15, 37.28) | |
Ozone | Model 1 | 258/258 | 0.57 (0.34, 0.93) | 75/75 | 0.49 (0.24, 1.03) |
Model 2 | 258/258 | 3.10 (0.93, 10.30) | 75/75 | 0.45 (0.11, 1.86) |
Pollutants . | Model . | CRS without nasal-polyps . | CRS with nasal polyps . | ||
---|---|---|---|---|---|
n (case/control) . | ORs (95% CI) . | n (case/control) . | ORs (95% CI) . | ||
PM2.5 | Model 1 | 308/308 | 7.19 (2.54, 20.36) | 91/91 | 3.98 (0.88, 18.01) |
Model 2 | 308/308 | 3.32 (0.63, 17.40) | 91/91 | 3.76 (0.35, 39.85) | |
PM10 | Model 1 | 213/213 | 0.97 (0.67, 1.40) | 66/66 | 1.10 (0.75, 1.62) |
Model 2 | 213/213 | 0.97 (0.49, 1.91) | 66/66 | 7.34 (0.83, 65.00) | |
NO2 | Model 1 | 132/132 | 0.65 (0.36, 1.18) | 35/35 | 0.89 (0.37, 2.15) |
Model 2 | 132/132 | 0.85 (0.27, 2.69) | 35/35 | 2.37 (0.15, 37.28) | |
Ozone | Model 1 | 258/258 | 0.57 (0.34, 0.93) | 75/75 | 0.49 (0.24, 1.03) |
Model 2 | 258/258 | 3.10 (0.93, 10.30) | 75/75 | 0.45 (0.11, 1.86) |
For PM2.5, PM10, and NO2, we used 5-µg/m3 unit increase; for ozone, we used each 1 IQR increase (0.005 units). Model 1 adjusted for age, gender, and diagnosis year. Model 2 further adjusted for smoking status. In the CRS without nasal-polyps group (n = 308), we have missing exposure data for PM10 (95 cases), NO2 (176 cases), and ozone (50 cases) in this study due to missing air pollution exposure from local EPA monitors. In the CRS with nasal-polyps group (n = 91), we have missing exposure data for PM10 (25 cases), NO2 (56 cases), and ozone (16 cases) in this study due to missing air pollution exposure from local EPA monitors.
12-Month Air Pollution Exposure and the Risk of CRS by Nasal Polyp Status in ADSMs
Pollutants . | Model . | CRS without nasal-polyps . | CRS with nasal polyps . | ||
---|---|---|---|---|---|
n (case/control) . | ORs (95% CI) . | n (case/control) . | ORs (95% CI) . | ||
PM2.5 | Model 1 | 308/308 | 7.19 (2.54, 20.36) | 91/91 | 3.98 (0.88, 18.01) |
Model 2 | 308/308 | 3.32 (0.63, 17.40) | 91/91 | 3.76 (0.35, 39.85) | |
PM10 | Model 1 | 213/213 | 0.97 (0.67, 1.40) | 66/66 | 1.10 (0.75, 1.62) |
Model 2 | 213/213 | 0.97 (0.49, 1.91) | 66/66 | 7.34 (0.83, 65.00) | |
NO2 | Model 1 | 132/132 | 0.65 (0.36, 1.18) | 35/35 | 0.89 (0.37, 2.15) |
Model 2 | 132/132 | 0.85 (0.27, 2.69) | 35/35 | 2.37 (0.15, 37.28) | |
Ozone | Model 1 | 258/258 | 0.57 (0.34, 0.93) | 75/75 | 0.49 (0.24, 1.03) |
Model 2 | 258/258 | 3.10 (0.93, 10.30) | 75/75 | 0.45 (0.11, 1.86) |
Pollutants . | Model . | CRS without nasal-polyps . | CRS with nasal polyps . | ||
---|---|---|---|---|---|
n (case/control) . | ORs (95% CI) . | n (case/control) . | ORs (95% CI) . | ||
PM2.5 | Model 1 | 308/308 | 7.19 (2.54, 20.36) | 91/91 | 3.98 (0.88, 18.01) |
Model 2 | 308/308 | 3.32 (0.63, 17.40) | 91/91 | 3.76 (0.35, 39.85) | |
PM10 | Model 1 | 213/213 | 0.97 (0.67, 1.40) | 66/66 | 1.10 (0.75, 1.62) |
Model 2 | 213/213 | 0.97 (0.49, 1.91) | 66/66 | 7.34 (0.83, 65.00) | |
NO2 | Model 1 | 132/132 | 0.65 (0.36, 1.18) | 35/35 | 0.89 (0.37, 2.15) |
Model 2 | 132/132 | 0.85 (0.27, 2.69) | 35/35 | 2.37 (0.15, 37.28) | |
Ozone | Model 1 | 258/258 | 0.57 (0.34, 0.93) | 75/75 | 0.49 (0.24, 1.03) |
Model 2 | 258/258 | 3.10 (0.93, 10.30) | 75/75 | 0.45 (0.11, 1.86) |
For PM2.5, PM10, and NO2, we used 5-µg/m3 unit increase; for ozone, we used each 1 IQR increase (0.005 units). Model 1 adjusted for age, gender, and diagnosis year. Model 2 further adjusted for smoking status. In the CRS without nasal-polyps group (n = 308), we have missing exposure data for PM10 (95 cases), NO2 (176 cases), and ozone (50 cases) in this study due to missing air pollution exposure from local EPA monitors. In the CRS with nasal-polyps group (n = 91), we have missing exposure data for PM10 (25 cases), NO2 (56 cases), and ozone (16 cases) in this study due to missing air pollution exposure from local EPA monitors.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.